Congress Asset Management Co. Purchases 17,127 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Congress Asset Management Co. lifted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 16.8% in the 3rd quarter, Holdings Channel reports. The fund owned 118,941 shares of the company’s stock after acquiring an additional 17,127 shares during the quarter. Congress Asset Management Co.’s holdings in Acadia Healthcare were worth $7,542,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Point72 Asset Management L.P. increased its stake in shares of Acadia Healthcare by 266.0% in the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after acquiring an additional 1,650,040 shares in the last quarter. Millennium Management LLC increased its stake in shares of Acadia Healthcare by 3,067.8% during the second quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after purchasing an additional 1,055,894 shares in the last quarter. William Blair Investment Management LLC lifted its holdings in shares of Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its position in shares of Acadia Healthcare by 67.9% in the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock worth $49,541,000 after purchasing an additional 296,625 shares in the last quarter. Finally, Clearline Capital LP purchased a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $11,179,000.

Analysts Set New Price Targets

Several equities research analysts have commented on ACHC shares. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. Barclays dropped their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Acadia Healthcare has a consensus rating of “Hold” and a consensus target price of $86.67.

Acadia Healthcare Stock Down 18.0 %

Shares of Acadia Healthcare stock opened at $42.69 on Friday. Acadia Healthcare Company, Inc. has a twelve month low of $42.46 and a twelve month high of $87.77. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The company’s 50 day moving average is $67.15 and its 200 day moving average is $68.18. The company has a market cap of $3.96 billion, a price-to-earnings ratio of 14.00, a price-to-earnings-growth ratio of 1.57 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the prior year, the firm earned $0.91 EPS. The company’s revenue was up 8.7% compared to the same quarter last year. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.